BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28111382)

  • 1. Aldosterone excess may inhibit insulin secretion: A comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism.
    Tsurutani Y; Sugisawa C; Ishida A; Inoue K; Saito J; Omura M; Nagasaka S; Nishikawa T
    Endocr J; 2017 Mar; 64(3):339-346. PubMed ID: 28111382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma.
    Komada H; Hirota Y; So A; Nakamura T; Okuno Y; Fukuoka H; Iguchi G; Takahashi Y; Sakaguchi K; Ogawa W
    Diabetes Metab; 2020 Jun; 46(3):236-242. PubMed ID: 31676325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in glucose metabolism based on 75-g oral glucose tolerance tests before and after surgery for adrenal Cushing's syndrome.
    Tsurutani Y; Miyoshi K; Inoue K; Takiguchi T; Saito J; Omura M; Nishikawa T
    Endocr J; 2019 Mar; 66(3):207-214. PubMed ID: 30674738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
    Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
    J Urol; 1995 Jun; 153(6):1775-80. PubMed ID: 7752314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.
    Fischer E; Adolf C; Pallauf A; Then C; Bidlingmaier M; Beuschlein F; Seissler J; Reincke M
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2513-20. PubMed ID: 23539730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism.
    Urbanet R; Pilon C; Calcagno A; Peschechera A; Hubert EL; Giacchetti G; Gomez-Sanchez C; Mulatero P; Toffanin M; Sonino N; Zennaro MC; Giorgino F; Vettor R; Fallo F
    J Clin Endocrinol Metab; 2010 Aug; 95(8):4037-42. PubMed ID: 20484481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary aldosteronism with aldosterone-producing adrenal adenoma in a pregnant woman.
    Fujiyama S; Mori Y; Matsubara H; Okada S; Maruyama K; Masaki H; Yonemoto T; Nagata T; Umeda Y; Matsuda T; Iwasaka T; Inada M
    Intern Med; 1999 Jan; 38(1):36-9. PubMed ID: 10052740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of bilateral aldosterone-producing adenomas differentiated by segmental adrenal venous sampling for bilateral adrenal sparing surgery.
    Morimoto R; Satani N; Iwakura Y; Ono Y; Kudo M; Nezu M; Omata K; Tezuka Y; Seiji K; Ota H; Kawasaki Y; Ishidoya S; Nakamura Y; Arai Y; Takase K; Sasano H; Ito S; Satoh F
    J Hum Hypertens; 2016 Jun; 30(6):379-85. PubMed ID: 26538381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
    Amar L; Plouin PF; Steichen O
    Orphanet J Rare Dis; 2010 May; 5():9. PubMed ID: 20482833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Woman with Normotensive Primary Hyperaldosteronism.
    Moradi S; Shafiepour M; Amirbaigloo A
    Acta Med Iran; 2016 Feb; 54(2):156-8. PubMed ID: 26997605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.
    Lin YH; Lin LY; Chen A; Wu XM; Lee JK; Su TC; Wu VC; Chueh SC; Lin WC; Lo MT; Wang PC; Ho YL; Wu KD;
    Atherosclerosis; 2012 Mar; 221(1):154-9. PubMed ID: 22197109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors determining cardiovascular and renal outcomes after adrenalectomy in patients with aldosterone-producing adrenal adenoma.
    Chiou TT; Chiang PH; Fuh M; Liu RT; Lee WC; Lee WC; Ng HY; Tsai YC; Chuang FR; Huang CC; Lee CT
    Tohoku J Exp Med; 2009 May; 218(1):17-24. PubMed ID: 19398869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP; Ragazzo F; Seccia TM; Maniero C; Barisa M; Calò LA; Frigo AC; Fassina A; Pessina AC
    Hypertension; 2012 Aug; 60(2):431-6. PubMed ID: 22733469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Aldosteronism Decreases Insulin Secretion and Increases Insulin Clearance in Humans.
    Adler GK; Murray GR; Turcu AF; Nian H; Yu C; Solorzano CC; Manning R; Peng D; Luther JM
    Hypertension; 2020 May; 75(5):1251-1259. PubMed ID: 32172621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic variation of CYP11B2 predicts postoperative resolution of hypertension in patients undergoing adrenalectomy for aldosterone-producing adenomas.
    Wang W; Hu WL; Zhang LC; Xiao YS; Liu J; Bin C
    Int J Urol; 2012 Sep; 19(9):813-20. PubMed ID: 22650983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness.
    Stowasser M; Klemm SA; Tunny TJ; Storie WJ; Rutherford JC; Gordon RD
    Clin Exp Pharmacol Physiol; 1994 Apr; 21(4):319-22. PubMed ID: 7923899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction.
    Hung CS; Chou CH; Wu XM; Chang YY; Wu VC; Chen YH; Chang YS; Tsai YC; Su MJ; Ho YL; Chen MF; Wu KD; Lin YH;
    J Hypertens; 2015 Sep; 33(9):1922-30; discussion 1930. PubMed ID: 26103125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.